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The effects of intro-oral parathyroid 
hormone on the healing of tooth 
extraction socket: an experimental 
study on hyperglycemic rats
Objective: To investigate the effects of intro-oral injection of parathyroid 
hormone (PTH) on tooth extraction wound healing in hyperglycemic rats. 
Methodology: 60 male Sprague-Dawley rats were randomly divided into the 
normal group (n=30) and DM group (n=30). Type 1 diabetes mellitus (DM) was 
induced by streptozotocin. After extracting the left first molar of all rats, each 
group was further divided into 3 subgroups (n=10 per subgroup), receiving 
the administration of intermittent PTH, continuous PTH and saline (control), 
respectively. The intermittent-PTH group received intra-oral injection of PTH 
three times per week for two weeks. A thermosensitive controlled-release 
hydrogel was synthesized for continuous-PTH administration. The serum 
chemistry was determined to evaluate the systemic condition. All animals 
were sacrificed after 14 days. Micro-computed tomography (Micro-CT) and 
histological analyses were used to evaluate the healing of extraction sockets. 
Results: The level of serum glucose in the DM groups was significantly higher 
than that in the non-DM groups (p<0.05); the level of serum calcium was 
similar in all groups (p>0.05). Micro-CT analysis showed that the DM group 
had a significantly lower alveolar bone trabecular number (Tb.N) and higher 
trabecular separation (Tb.Sp) than the normal group (p<0.05). The histological 
analyses showed that no significant difference in the amount of new bone (hard 
tissue) formation was found between the PTH and non-PTH groups (p>0.05). 
Conclusions: Bone formation in the extraction socket of the type 1 diabetic 
rats was reduced. PTH did not improve the healing of hard and soft tissues. 
The different PTH administration regimes (continuous vs. intermittent) had 
similar effect on tissue healing. These results demonstrated that the metabolic 
characteristics of the hyperglycemic rats produced a condition that was unable 
to respond to PTH treatment.
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Introduction
Diabetes mellitus (DM) has an increasingly 
higher occurrence of 463 million adults worldwide.1 
People with DM are more likely to suffer from earlier 
detrimental oral status and are prone to numerous 
oral diseases, including oral infection, periodontitis and 
difficulties in wound healing after tooth extraction.2 It 
has been found that the prevalence of tooth extractions 
in DM patients is 1.88 times higher than the general 
population.3 
The high-glucose microenvironment would delay 
the healing of tooth extraction sockets.4 High glucose 
could affect the osteoblastic function and matrix 
mineralization.5 The soft tissue repair is associated 
with the defect in the formation of granulation tissue 
and collagen degradation induced by excessive matrix 
metalloproteinase.6 The dysfunction of fibroblast could 
impair the collagen synthesis, resulting in decreased 
fiber accumulation.7 Many studies have explored 
different approaches to accelerate the healing of 
tooth extraction sockets under DM conditions, such 
as the use of growth factors,8 graft fillings,9 ellagic 
acid,10 and low-level laser therapy.11 The effectiveness 
of these approaches, however, is unsatisfactory due 
to the complexity of DM and vulnerability of the oral 
environment.12 
Parathyroid hormone (PTH) is one of the important 
hormones to maintain the balance of the calcium and 
phosphorus metabolism.13 PTH can regulate osteoclast 
activity and influence bone remodeling, and is currently 
the only clinical drug to promote osteogenesis for 
the treatment of osteoporosis.14 The intermittent 
administration of PTH has been found to directly inhibit 
transcription of the sclerosis gene and stimulate bone 
formation;15 the continuous administration of PTH 
could increase the receptor activator of the nuclear 
factor-kB ligand/osteoprotegerin ratio, resulting in an 
increased osteoclastogenesis.16 PTH could also benefit 
the healing of soft tissue via suppressing inflammation 
and stimulating collagen deposition.4 A recent study 
has reported that PTH promoted the healing of both 
hard and soft tissues in the tooth extraction socket.17 
The effect of PTH on extraction socket healing under 
DM condition remains unclear. The aim of this study 
was to investigate and compare the effects of local 
administration (intro-oral injection) of intermittent- 
and continuous-PTH on the healing of tooth extraction 
sockets in hyperglycemic rats. 
Methodology
Synthesis and characterization of PTH 
controlled-release hydrogel
A thermosensitive and injectable hydrogel was 
prepared for the continuous administration of 
PTH based on the literature.18 The poly (ethylene 
glycol)-poly (caprolactone)-poly (ethylene glycol) 
thermosensitive hydrogel (PEG-PCL-PEG, PECE) was 
synthesized by ring-opening copolymerization.19 The 
1H Nuclear Magnetic Resonance (1H NMR) spectra (in 
CDCl3) was recorded on a Varian 400 spectrometer 
(Varian, USA) at 400 MHz to characterize chemical 
composition of PECE copolymers.
The sol–gel–sol phase transition behavior was 
carried out as follows: PECE hydrogel was placed into 
5 mL EP tube and incubated in a water bath at 0°C 
for ten min, and then was slowly heated at a rate of 
0.5°C/min until 37°C. The sol–gel–sol phase transition 
diagram was recorded using the test tube-inverting 
method, which was visually observed by inverting the 
tube. The condition of sol and gel phase was defined 
as “flow liquid sol” and “no flow solid gel”.
In vitro release tests at body temperature were 
carried out as follows: firstly, 750 μL hydrogel loaded 
with 1 mg BAS protein was placed into the bottom of 
the EP tube at 37°C for 1 h to form the gel. Then, 1000 
μL Milli-Q water was added into the tube to immerse 
the gel. Then, the sample was kept and shaken at 106 
rpm at 37°C. The solution was collected at each time of 
interest (T=0,1, 2, 4, 8, 12, 24 h in the first day, and at 
each 24 h interval until 336 h) and replaced with 1000 
μL preheated fresh Milli-Q water. After centrifugation 
at 13,000 rpm for 10 min, the measured extracts were 
stored at −20°C for drug release analysis. The amount 
of released protein at each time points was assessed 
in triplicate using the Enhanced BCA Protein Assay 
kit (Beyotime technology, Beijing, China) following 
manufacturer’s instructions. The accumulative release 
percent of BSA protein was calculated.
Animal model and tooth extraction
A total of 60 young male Sprague-Dawley rats 
(5 weeks old) were included in the study. Sample 
size was calculated by power analysis based on the 
estimated effect size reported in the previous study.20 
Rats were housed at 22 ºC, 40% humidity, and in 
12-hour daylight cycles. Rats were allowed access to 
standard laboratory rodent diet and water. The ethics 
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of the study was approved by the Research Ethics 
Committee of West China Hospital of Stomatology (No. 
201610610379). The study was presented following 
the Animal Research N3CRs guidelines for Reporting 
of In Vivo Experiments (ARRIVE) guidelines. 
Sixty rats were randomly divided into two groups 
(n=30 per group), including the normal control and the 
diabetic group. Diabetes was induced into 12h-fasted 
rats by intraperitoneally streptozotocin (STZ) (Sigma, 
St Louis, MO, USA) dissolved in citrate buffer (pH=4.2-
4.5). STZ was calculated at 45 mg/kg.21 Three days 
after the STZ injection, blood was obtained from the 
tail vein, and glucose levels were measured using a 
glucometer (Yuwell, Jiangsu, China). Diabetes was 
confirmed twice by the presence of random blood 
glucose concentrations of >16.7 mmol/L.10
The mandibular left first molar was extracted 
under general anesthesia (10% chloral hydrate 
solution, 0.32ml/100g) from each animal. Sterile 
dental instruments were used during the extraction 
of molars, and teeth removal was performed by using 
a sharpened dental explorer.22 Alveolar sockets were 
left to heal without sutures. 
Grouping and administration of PTH
After tooth extraction, the two groups were divided 
randomly into 3 subgroups (n=10 per group), including 
the normal saline (NS), the intermittent-PTH (iPTH) 
and the continuous-PTH group (cPTH).
The intermittent intra-oral injection of PTH (1-34) 
(Chinese Peptide, Hangzhou, China) was administered 
at a dose of 80 μg/kg three times a week for 14 days.17, 
23 It was dissolved in normal saline solution, and the 
needle was placed in the buccal vestibule next to the 
tooth extraction site.
The continuous intra-oral injection of PTH (1-
34) was administered as follows: PECE was mixed 
and dissolved completely in NS to form sol in the 
temperature of 55-60ºC at a concentration of 25 
wt% and cooled at 0 ºC for three minutes.19 Then, 
PTH (1-34) solution was mixed into the PECE sol to 
form suspension, and the PTH (1-34) gel to release 
slowly for 14 days was obtained. Soon after the tooth 
extraction, PECE hydrogel loaded with an equivalent 
dosage of PTH (1-34) in iPTH group was put in the 
tooth socket. 
Animals in the two NS groups (NS normal group 
and NS diabetic group) were injected with the same 
volume of normal saline solution three times a week 
for 14 days.
Serum chemistry
Blood was collected from carotid artery at the time 
of euthanasia, which was 24 h after the last injection 
of PTH. Serum samples were prepared and used 
immediately. The levels of calcium were measured 
using a commercial kit (Jiancheng, Nanjing, China). 
The blood glucose levels from the tail vein of each 
group were monitored once every week using a 
glucometer (Yuwell, Jiangsu, China). Diabetic rats 
with unsatisfactory serum glucose levels would be 
removed; however, no animal was excluded for this 
reason.
Micro computed tomography (Micro-CT) 
assessment
Rats were euthanized at the end of the designated 
injection period of 14 days. The mandibles were 
dissected, and fixed in 10% formalin, and the 
extraction wounds were scanned by Micro-CT (Micro-
CT50, Scanco Medical, Bassersdorf, Switzerland) at 
10 μm voxel resolution with the beam energy level 
of 70 kVp and electrical current of 0.2 mA. The time 
of scanning was 858 ms. Each mandible was fixed 
by upside-down styrofoam, and the occlusal plane 
became horizontal to the bottom. The conservation of 
the samples occured in 10% formalin. The thresholds 
were determined visually in several slices. Trabecular 
parameters were identified by the direct measurement 
technique. The region of interest was a trabecular 
compartment of 100 slices around extraction sockets 
and was segmented by semi-manual contour. Alveolar 
bone trabecular number (Tb.N), trabecular thickness 
(Tb.Th), trabecular separation (Tb.Sp) and bone 
mineral density (BMD) were analyzed with built-in 
software. 
Histomorphometric analysis
Rats were decapitated two weeks after the 
interventions. The specimens were demineralized in 
10% ethanol, paraffin-embedded, and sectioned to 5 
μm thickness. Hematoxylin and eosin (HE) (Beyotime 
technology, Beijing, China) and Masson’s trichrome 
(Sigma, St Louis, MO, USA) staining techniques were 
performed for the detection of bone tissue and collagen 
fibers respectively, following the manufacturer’s 
instructions. The staining sections were analyzed by 
Image-Pro Plus (Media Cybernetics, Bethesda, MD, 
USA). New alveolar bone formation was quantified in 
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the extraction wounds as described previously.20   
Statistics analysis
Statistical analyses were performed using the 
SPSS statistics base 17 (SPSS Inc., Chicago, IL, USA). 
Results are presented as mean±standard deviation. 
The normality test was performed using the Shapiro-
Wilk analysis; the statistical comparisons were 
analyzed by the Student’s t-test, one-way ANOVA, 
and two-way ANOVA, with a significance level of 5%. 
Statistical significance was defined as 0.05 α-level.
Results
Characterization of PTH controlled-release 
hydrogel
The chemical structure of PECE gel was characterized 
by 1H NMR (Figure 1). The peak of the caprolactone 
unit and the ethylene glycol unit were at 3.98 ppm and 
3.57 ppm, respectively. The macromolecular weight 
estimated from 1H NMR spectrum was 3246, which was 
consistent with theoretical estimation, indicating that 
the PECE gel was synthesized successfully. 
The temperature-dependent sol–gel phase 
transition behavior was presented in Figure 2A. The 
hydrogel showed a sol state at lower temperature 
(0°C) and a gel state at body temperature (37°C). 
The hydrogel underwent sol-gel-sol phase transition 
as the temperature increased and slowly released PTH 
at local part, which prolonged the therapeutic effect 
time and reduced the repeated injections.
The controlled-release ability of PECE hydrogel 
is shown in Figure 2B. The release rate of the drug 
was rapid in the first 168 hours, and then became 
comparatively slow and sustained in the next 168 
hours. The cumulative release of protein reached 
58.24% by the 14th day. Therefore, the experiment 
period for the PTH controlled-release hydrogel was set 
as 14 days in this study.
Serum chemistry
The level of serum glucose in the DM groups 
(DM+NS, DM+iPTH and DM+cPTH) (mean 22.38±2.71 
mmol/L, with no significant difference within the three 
groups, p>0.05) was significantly higher than the non-
DM groups (NOR+NS, NOR+iPTH and NOR+cPTH), 
(mean 5.82±0.67 mmol/L) (p<0.01), indicating that 
the DM model was successfully established in the 
study. 
No statistical significance of the serum calcium 
concentration was found either between the DM and 
non-DM groups, or within these groups (p>0.05 for 
all). Local administration in the extraction socket in 
the study could reduce the systematic effects of PTH, 
such as hypercalcemia, which was reflected by the 
unaltered serum calcium level. 
Micro-CT analysis of the extraction socket
The Micro-CT analysis (Figure 3) showed that 
the Tb.N in NOR+NS group (2.37 ± 0.29 mm-1) was 
significantly higher than that in DM+NS group (1.52 
± 0.14 mm-1) (p<0.01) (Figure 1E), while the Tb.Sp 
in NOR+NS group (0.21 ± 0.09 mm) was significantly 
lower than that in DM+NS group (0.47±0.05 mm) 
(p<0.05) (Figure 1F), indicating that bone density was 
affected by the DM condition. No significant difference 
Figure 1- 1H NMR spectrum of PECE copolymer. The peak of (A) caprolactone unit and (B) ethtlene glycol unit were at 3.98ppm and 
3.57ppm, respectively
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Figure 2- Characterization of PTH controlled-release hydrogel (A) The sol-gel phase transition behavior of PECE hydrogel: the solution 
state of hydrogel at 0°C and the gel state of hydrogel at 37 °C. (B) The cumulative release of drug-loaded PECE hydrogel for 14 days
Figure 3- Micro-CT analysis of the extraction socket. (A) Cross section of the Micro-CT scan in the extraction socket; (B) Sagittal plane 
of the Micro-CT scan in the DM+iPTH group; (C) Sagittal plane of the Micro-CT scan in DM+NS group; (D) 3D reconstruction of the 
extraction socket in DM+PTH group. (E), (F), (G) and (H) Micro-CT analysis of Tb.N, Tb.Sp, Tb.Th and BMD. Tb.N in NOR+NS group was 
significantly higher than that in DM+NS group (p<0.01), while the Tb.Sp in NOR+NS group was significantly lower than that in DM+NS 
group (p<0.05). PTH therapy for 14 days induced no detectable bone anabolic effect in alveolar socket bone parameters
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was found among all the other groups for the alveolar 
bone Tb.Th and BMD (p>0.05 for all). Bone formation 
in the extraction socket under the DM conditions in the 
study was significantly less than that under non-DM 
condition, indicating an impaired hard-tissue healing 
of extraction socket under DM condition.
There is no significant difference of Tb.N, Tb.Th, 
Tb.Sp and BMD between the PTH and NS groups 
(p>0.05 for all), indicating that the effect of PTH on 
tooth extraction socket in normal and DM rats was 
minimal (Figure 2 E-H).
Histological analysis of the extraction socket
The histological analysis of soft tissue (HE and 
Masson’s trichrome staining) showed that more 
collagen in the extraction socket was observed in the 
groups treated with PTH (both iPTH and cPTH) than 
those not treated with PTH (Figure 4A and B). The 
quantitative analysis of hard tissue (new alveolar bone 
formation) showed no statistical significance between 
DM and non-DM groups or between NS and PTH groups 
(p>0.05) (Figure 4C). 
Discussion
In this study, bone formation in the extraction 
socket in the DM rats was decreased when compared to 
that of the normal control rats. PTH (1-34) showed no 
obvious results in hard tissue formation and soft tissue 
healing. No difference was found on the healing of 
extraction socket between intermittent and continuous 
administration of PTH. These findings suggest that 
hyperglycemic rats failed to benefit from the anabolic 
treatment of PTH on the healing of extraction socket 
in the high glucose condition.
Figure 4- Histological analysis of the extraction socket. (A) Masson’s trichrome staining (red parts meant new bone and light blue parts 
meant collagen. Scale bar: 100μm); (B) HE staining; and (C) New alveolar bone formation in the tooth extraction socket. PTH therapy for 
14 days induced no detectable new alveolar bone formation
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The effectiveness of PTH on promoting the 
healing of tooth extractions in the diabetic rats was 
not significant in the study. This may be due to the 
metabolic characteristics of hyperglycemic rats leading 
to a condition of ineffective PTH treatment. Some 
studies showed that PTH did not increase the insulin-
immunoreactivity of β-cells of the pancreatic islets in 
diabetic rats.24 The inflammation caused by diabetes 
would disrupt vascular endothelial cell function.25 The 
expression of inflammatory cytokines such as TNF-α, 
IL-1 and IFN-γ in bone increased,26, 27 which contributed 
to the delayed healing of extraction sockets. Moreover, 
the high level of advanced glycosylation end products 
and collagen cross-linking may cause an overall 
negative effect on diabetic bone mechanics.28 
Therefore, metabolic control of hyperglycemia may 
be a key factor when patients with diabetes receive 
anabolic therapy to improve bone mass. Future studies 
could explore the anabolic property of PTH in the 
DM condition when hyperglycemia is controlled with 
insulin, and immunolabeling or molecular analyses 
could be performed to further evaluate the possible 
anabolic activity of PTH and signaling pathways.
The histological analyses in the study showed that 
the PTH treatment showing more collagen formation 
demonstrated an anabolic effect on soft tissue healing. 
In response to hyperglycemia, advanced glycosylation 
end products were induced and covalently bounded 
to reactive amino groups, resulting in a dysfunction 
of the epithelial cells and extracellular matrix.7 This 
is coincident with the decreased collagen in the 
extraction socket in the DM rats. This may be due to 
the microcirculation defect and insufficient oxygen 
caused by thickened and inelastic vessel wall.29 
Several studies have shown double effects of PTH 
(1-34) – anabolic when administered intermittently 
and catabolic when applied continuously.30 The 
subcutaneous and intermittent administration of 
PTH facilitated the hard and soft tissue repair in 
tooth extract socket at the dose of 80 μg/kg daily.4 
Intermittent and systemic PTH administration 
reduced alveolar bone loss by decreasing the receptor 
activator of nuclear factor kappa B ligand (RANKL)/
osteoprotegerin (OPG) ratio in hyperglycemic rats.23 
However, in the continuous administration of PTH, the 
expression of Phospho1 and Smpd3 in osteoblasts 
decreased,16 resulting in the suppression of bone 
formation mediated by Cox2.31 
Due to the biological nature of hard-tissue healing 
in the tooth extraction socket,32 this study mainly 
focused on the effects of PTH on bone formation rather 
than resorption. However, hyperglycemic rats failed to 
benefit from the anabolic treatment. The contradictory 
action of PTH might be caused by double effect on 
bone formation and bone resorption. The anabolic 
role of iPTH could be lessened by the catabolic effect 
of DM.33 At the early stage of bone and cartilage 
healing process, both administrations of PTH could 
promote osteogenic differentiation.34 The cPTH did 
not suppress osteogenesis, but the catabolic role on 
bone metabolism was greater than its anabolic role, 
resulting in bone loss. The cPTH increased slightly 
undifferentiated mesenchymal stem cell, osteoblast 
and osteocyte number at 14 days.35 This may result 
in the non-significant difference between two regimes 
of PTH. Another possible reason might be that the rats 
used in the study were male. The cPTH was found to 
be not catabolic in male rats, as no change was found 
in BMD and cortical thickness in males.36
The experiment period adopted in this study was 
two weeks. This was in consideration of the optimal 
slow-release effect of the PECE hydrogel. Furthermore, 
the epithelialization was generally complete and 
well-keratinized at approximately two weeks.37, 38 
The maximum bone formation was achieved and the 
woven bone completely filled the extraction socket,4 
and almost replaced by substance with a radio-opacity 
during that timeframe,37 so 14 days was appropriate 
for this study. The long-term effects of PTH on the 
healing of extraction socket under hyperglycemic 
conditions need further investigation. 
Conclusion
Bone formation in the extraction socket under the 
DM condition was reduced. Hyperglycemic rats failed to 
benefit from the PTH treatment in the healing of tooth 
extraction sockets. The different PTH administration 
regimes (intermittent vs. continuous) had similar 
effects on the tissues healing.
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